Demographics (1)
- SEX - Biological sex (phv00536832.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for LAR (luminal androgen receptor)-enriched triple-negative breast cancer (TNBC) (phv00536836.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00536839.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00536838.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00536831.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00536841.v1.p1)
- IS_TUMOR - Tumor status (phv00536840.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00536842.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00536843.v1.p1)
- SAMPLE_ID - Sample ID (phv00536837.v1.p1)
- SAMPLE_ID - Sample ID (phv00536834.v1.p1)
- SUBJECT_ID - Subject ID (phv00536830.v1.p1)
- SUBJECT_ID - Subject ID (phv00536833.v1.p1)
- SUBJECT_ID - Subject ID (phv00536835.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00536844.v1.p1)